Bayesian Capital Management’s Bath & Body Works BBWI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,279
Closed -$548K 549
2025
Q2
$548K Buy
+18,279
New +$535K 0.09% 266
2025
Q1
Sell
-70,179
Closed -$2.72M 620
2024
Q4
$2.72M Buy
+70,179
New +$2.35M 0.33% 86
2024
Q2
Sell
-45,524
Closed -$2.28M 737
2024
Q1
$2.28M Buy
45,524
+13,600
+43% +$611K 0.22% 128
2023
Q4
$1.38M Buy
+31,924
New +$1.08M 0.15% 173
2023
Q3
Sell
-10,614
Closed -$398K 700
2023
Q2
$398K Buy
+10,614
New +$388K 0.04% 458
2023
Q1
Sell
-6,904
Closed -$291K 782
2022
Q4
$291K Buy
+6,904
New +$257K 0.04% 493
2022
Q3
Sell
-18,204
Closed -$490K 704
2022
Q2
$490K Buy
+18,204
New +$790K 0.09% 340
2022
Q1
Sell
-18,700
Closed -$1.3M 777
2021
Q4
$1.3M Buy
+18,700
New +$1.33M 0.41% 61
2021
Q1
Sell
-36,739
Closed -$1.1M 533
2020
Q4
$1.1M Buy
+36,739
New +$1.07M 0.29% 92
2017
Q3
Sell
-12,934
Closed -$563K 476
2017
Q2
$563K Buy
+12,934
New +$530K 0.21% 164
2016
Q4
Sell
-17,442
Closed -$998K 599
2016
Q3
$998K Buy
+17,442
New +$1.03M 0.66% 21

Other funds holding BBWI

Bayesian Capital Management's BBWI Position: Q3 2025 in Review

Bayesian Capital Management sold out of Bath & Body Works (BBWI) in Q3 2025, closing a stake of 18,279 shares — an estimated $548K sold.

Bayesian Capital Management first reported a position in BBWI in Q3 2016 and held it in 11 quarters. The position peaked at $2.72M in Q4 2024. 474 funds tracked by Wall St. Rank hold BBWI as of Q3 2025.

  • Bayesian Capital Management reported no remaining Bath & Body Works position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 18,279 Bath & Body Works shares in Q3 2025, an estimated $548K.
  • Bayesian Capital Management first reported a position in Bath & Body Works in Q3 2016 and held it in 11 quarters.
  • Bayesian Capital Management's Bath & Body Works position peaked at $2.72M in Q4 2024.
  • 474 funds tracked by Wall St. Rank held Bath & Body Works as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.